Sign In
Buy PYNKF
$0.200
-0.0055 (-2.68%)
At Close: Jun 23, 2026
Perimeter Medical Imaging AI to Participate in the Planet MicroCap Showcase in Las Vegas
04:30pm, Monday, 15'th Jun 2026
TORONTO and DALLAS, June 15, 2026 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, is plea
Perimeter Selected for INOVAIT Pilot Fund to Advance AI for Breast Cancer Surgery
09:05am, Tuesday, 09'th Jun 2026
Canadian government-backed contribution supports next-generation AI development for Claire™, Perimeter's flagship intraoperative imaging platform TORONTO, June 9, 2026 /PRNewswire/ - Perimeter Medi
Perimeter Medical Imaging AI, Inc. (PINK:CA) Q1 2026 Earnings Call Transcript
08:54pm, Thursday, 28'th May 2026
Perimeter Medical Imaging AI, Inc. (PINK:CA) Q1 2026 Earnings Call Transcript
Perimeter Announces First Quarter 2026 Financial Results
04:40pm, Thursday, 28'th May 2026
Conference call/webcast today at 5:00 pm ET TORONTO and DALLAS, May 28, 2026 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-
Perimeter Schedules First Quarter 2026 Financial Results Conference Call for May 28th
04:30pm, Thursday, 21'st May 2026
TORONTO and DALLAS, May 21, 2026 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, announce
Perimeter Showcases Claire™ for Intraoperative Breast Cancer Margin Assessment at ASBrS 2026
08:00am, Wednesday, 29'th Apr 2026
New advanced imaging and AI capabilities revealed for first time ahead of commercial launch TORONTO and DALLAS, April 29, 2026 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PY
Perimeter Medical Imaging AI to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference
07:45am, Tuesday, 14'th Apr 2026
TORONTO and DALLAS, April 14, 2026 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, is pleas
Perimeter Medical Imaging AI, Inc. (PINK:CA) Q4 2025 Earnings Call Transcript
10:02pm, Tuesday, 31'st Mar 2026
Perimeter Medical Imaging AI, Inc. (PINK:CA) Q4 2025 Earnings Call Transcript
Conference Call/Webcast Today at 5:00 pm ET TORONTO and DALLAS, March 31, 2026 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commerc
TORONTO and DALLAS, March 23, 2026 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, announce
Perimeter Medical Imaging AI's 'Claire' Becomes First FDA-approved AI-Enabled Imaging Device for Breast Cancer Surgery
05:06pm, Tuesday, 03'rd Mar 2026
Claire demonstrated a statistically significant reduction in patients with residual cancer post-surgery compared to the standard of care alone Social Capital's Chamath Palihapitiya highlights Claire a
Perimeter Announces Grant and Cancellation of Stock Options
08:00am, Tuesday, 17'th Feb 2026
TORONTO and DALLAS, Feb. 17, 2026 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, announce
Perimeter Medical Imaging AI Enters Systemwide Agreement with Intermountain Health
04:15pm, Thursday, 08'th Jan 2026
Agreement paves the way for deployment of Perimeter's advanced intraoperative imaging technology across the Mountain West TORONTO and DALLAS, Jan. 8, 2026 /PRNewswire/ - Perimeter Medical Imaging AI,
Perimeter Medical Imaging AI, Inc. (PINK:CA) Shareholder/Analyst Call Prepared Remarks Transcript
02:16pm, Monday, 29'th Dec 2025
Perimeter Medical Imaging AI, Inc. (PINK:CA) Shareholder/Analyst Call Prepared Remarks Transcript
Perimeter Medical Imaging AI Closes C$3.6 Million Non-Brokered Private Placement
04:05pm, Tuesday, 09'th Dec 2025
Led by insiders, including Perimeter's CEO Adrian Mendes Capital to accelerate the commercialization of the current S-Series and strengthen the balance sheet through the pending FDA decision of Perim
